title: Effects of short-term administration of sublingual nifedipine on coronary arterial wall elastic properties: evaluation by intravascular ultrasound.
abstract: Intravascular ultrasound is suited to measure coronary cross-sectional anatomy. Therefore the regional coronary wall elasticity was evaluated by examining the response to nifedipine. In 20 patients, coronary ostial pressure (P) and intravascular ultrasound images were simultaneously recorded before and after sublingual administration of 10 mg nifedipine. We identified the perimeter of the vessel wall, with normal or atherosclerotic plaque, on ultrasound image. At the atherosclerotic site, we measured segmental perimeter (S) for each normal or plaque segment. The ratio of the individual segment length (delta S/delta P) and cyclic variation of cross-sectional area (delta A/delta P) per mm Hg increase in P were calculated. Nifedipine decreased pressure (133/79-120/73 mm Hg) and increased heart rate (79-82 beats/min). After nifedipine, delta A/delta P increased from 8.5 +/- 10.2 x 10(-3) to 16.5 +/- 14.4 x 10(-3) mm2/mm Hg at 20 normal sites (p = 0.005) but was unchanged at 17 atherosclerotic sites (6.6 +/- 7.0 x 10(-3) to 6.7 +/- 7.1 x 10(-3) mm2/mm Hg). Nifedipine increased delta S/delta P in normal segments (4.5 +/- 8.7 x 10(-3) to 9.9 +/- 10.9 x 10(-3) mm/mm Hg; p = 0.02) but produced no change in segments with calcified or soft plaque (-1.1 +/- 0.3 x 10(-3) to 1.4 +/- 1.6 x 10(-3) mm/mm Hg and 5.0 +/- 3.6 x 10(-3) to 6.1 +/- 4.8 x 10(-3) mm/mm Hg, respectively). This study demonstrated that nifedipine increases regional coronary arterial elasticity at normal segments but not at that containing mildly atherosclerotic segment, and likely that the arterial wall function indicated by the response to nifedipine was impaired at an early stage of atherosclerosis.
authors.affiliation: Second Department of Internal Medicine, Kagawa Medical School, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Mizushige
authors.forename: A N
authors.initials: AN
authors.lastname: DeMaria
authors.forename: K
authors.initials: K
authors.lastname: Yoshikawa
authors.forename: M
authors.initials: M
authors.lastname: Yuba
authors.forename: H
authors.initials: H
authors.lastname: Morita
authors.forename: S
authors.initials: S
authors.lastname: Senda
authors.forename: H
authors.initials: H
authors.lastname: Matsuo
mesh_terms: D000286:Administration, Sublingual; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001794:Blood Pressure / Q000187:drug effects; D006328:Cardiac Catheterization; D003327:Coronary Disease / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000503:physiopathology*; D003331:Coronary Vessels / Q000000981:diagnostic imaging / Q000187:drug effects* / Q000473:pathology; D004548:Elasticity; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D009543:Nifedipine / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology*; D015588:Observer Variation; D011673:Pulsatile Flow / Q000187:drug effects; D014463:Ultrasonography; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology*
chemical_list: D014665:Vasodilator Agents; D009543:Nifedipine